Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Gruber

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Nature Plants|December 3, 2016
Giving fruit a nutritional boostKarl Gruber
The Lancet. Oncology|August 4, 2024
New immigration laws could undermine cancer research in the UKKarl Gruber
Nature Cancer|December 20, 2022
Cancer research in the midst of COVID-19Karl Gruber
The Lancet. Oncology|September 8, 2024
European Commission approval for Dutch investment in radiopharmaceuticalsKarl Gruber
The Lancet. Oncology|January 19, 2025
Cancer incidence associated with PFAS contamination of drinking water in the USAKarl Gruber
The Lancet. Oncology|January 26, 2025
India is boosting vaccination efforts to eradicate cervical cancerKarl Gruber
The Lancet. Oncology|February 8, 2026
New free trade agreement might bring cheaper cancer drugs to IndiaKarl Gruber
The Lancet. Oncology|July 21, 2024
Lifestyle factors driving cancer cases and mortality in the USAKarl Gruber
EMBO Reports|July 8, 2015
Here, there, and everywhere: From PCRs to next-generation sequencing technologies and sequence databases, DNA contaminants creep in from the most unlikely placesKarl Gruber
The Lancet. Oncology|September 7, 2025
Indian parliamentary committee seeks price cap for cancer drugsKarl Gruber
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Nature Plants|December 3, 2016
Giving fruit a nutritional boostKarl Gruber
The Lancet. Oncology|August 4, 2024
New immigration laws could undermine cancer research in the UKKarl Gruber
Nature Cancer|December 20, 2022
Cancer research in the midst of COVID-19Karl Gruber
The Lancet. Oncology|September 8, 2024
European Commission approval for Dutch investment in radiopharmaceuticalsKarl Gruber
The Lancet. Oncology|January 19, 2025
Cancer incidence associated with PFAS contamination of drinking water in the USAKarl Gruber
The Lancet. Oncology|January 26, 2025
India is boosting vaccination efforts to eradicate cervical cancerKarl Gruber
The Lancet. Oncology|February 8, 2026
New free trade agreement might bring cheaper cancer drugs to IndiaKarl Gruber
The Lancet. Oncology|July 21, 2024
Lifestyle factors driving cancer cases and mortality in the USAKarl Gruber
EMBO Reports|July 8, 2015
Here, there, and everywhere: From PCRs to next-generation sequencing technologies and sequence databases, DNA contaminants creep in from the most unlikely placesKarl Gruber
The Lancet. Oncology|September 7, 2025
Indian parliamentary committee seeks price cap for cancer drugsKarl Gruber
Pageof 23